I Gresser - Acta Oncologica, 1989 - informahealthcare.com Abstract Both natural and recombinant interferons have shown definite antitumor
activity in some patients with some malignancies. The history of the development
of interferon as an antitumor agent is reviewed, with special attention to ... Cited by 419 - Related articles - All 8 versions
TWJ Lennard, BK Shenton, A Borzotta, PK … - Br J Surg, 1985 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 274 - Related articles - All 3 versions
- ►ascopubs.org [PDF] JM Kirkwood, MS Ernstoff - Journal of Clinical Oncology, 1984 - jco.ascopubs.org From the Section of Medical Oncology, Yale University School of Medicine, Newi
Haven, Conn. Submitted August 29. 1983; accepted December 12, 1983. Supported in
part by grant no. CA 08341 ,fi-om the National Institutes of Health. ... Cited by 211 - Related articles - All 5 versions
KA Foon… - Cancer Res, 1989 - AACR Immunotherapy is divided into two overlapping categories, active and passive.
The goal of active immunotherapy is the stimulation of host ant
¡tumorimmunity, either cellular or hu moral. This can be accomplished in ... Cited by 163 - Related articles - All 3 versions
D Goldstein, J Laszlo - Cancer Res, 1986 - AACR Isaacs and Lindemann first characterized UN in England in 1957; they coined the
term to signify a protein elaborated by virally infected cells that functions to
prevent their infection by a second virus (1). However, difficulties with ... Cited by 141 - Related articles - All 3 versions
JA McDonald, L Caruso, P Karayiannis, LJ … - Hepatology, 1987 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 107 - Related articles - All 4 versions
JW Hadden - International journal of immunopharmacology, 1999 - Elsevier Adenocarcinomas of the breast behave clinically and epidemiologically in ways
that show host resistance factors are important for outcome in addition to grade
and stage of malignancy. Immune reactivity to autologous tumors is ... Cited by 95 - Related articles - BL Direct - All 6 versions
- ►nih.gov [PDF] BS Edwards, JA Merritt, RC Fuhlbrigge, EC … - Journal of Clinical Investigation, 1985 - pubmedcentral.nih.gov To define critical parameters concerning interferon (IFN) effects upon natural
killer (NK) cells in vivo, we gave cancer patients serial weekly intramuscular
injections of purified lymphoblastoid IFN in six doses ranging from 105 to ... Cited by 92 - Related articles - All 5 versions
GJ Mannering, LB Deloria - Annual review of pharmacology and toxicology, 1986 - Annual Reviews Early virologists observed that a patient or an experimental animal, once
recovered from a virus infection usually resisted reinfection from the same or
similar virus. Vaccination was one of the early applications of this phenom ... Cited by 81 - Related articles - All 4 versions
EC Borden, PM Sondel, T Biosciences, H … - CA A Cancer Journal for Clinicians - interscience.wiley.com Human proteins with identified effects on host responses to malignant cells have
been established as effective therapeutic techniques in cancer. Lymphokines,
products of activated cells of the immune system, have pleiotropic ... Cited by 79 - Related articles - All 2 versions
